Twin preterm neonates with cardiac toxicity related to lopinavir/ritonavir therapy

Pediatric Infectious Disease Journal

Volumn 28, Issue 12, 2009, Pages 1127-1129

  McArthur, Monica A ^a   Kalu, Stella U ^a,b   Foulks, Arlen R ^a,c   Aly, Ashraf M ^a,d   Jain, Sunil K ^a,c   Patel, Janak A ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Divisions of Pediatric Infectious Disease and Immunology   (United States)

^c Divisions of Neonatology ^*

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Antiretroviral therapy; Heart block; Lopinavir ritonavir

Indexed keywords

LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; ZIDOVUDINE;

ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CARDIOTOXICITY; CASE REPORT; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONGESTIVE CARDIOMYOPATHY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NAUSEA; NEWBORN; PREMATURITY; PRIORITY JOURNAL; SYMPTOM; TWINS; VOMITING;

EID: 74049102915     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181acd17e     Document Type: Article

References (7)

1. NIH Guidelines. Public Health Service Task Force. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States: July 2008. Available at: http://aidsinfo.nih.gov/contentfiles/ PerinatalGL.pdf. Accessed February 2009.
2. Lopriore E, Rozendaal L, Gelinck LB, et al. Twins with cardiomyopathy and complete heart block born to an HIV-infected mother treated with HAART. AIDS. 2007;21:2564-2565.
3. Chadwick EG, Pinto J, Yogev R, et al. Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age Pharmacokinetics and 24-week safety and efficacy. Pediatr Infect Dis J. 2009;28:215-219.
4. Jimenez FJ, Pinilla J, Repiso M, et al. Complete auriculoventricular block in a patient treatment with lopinavir/ritonavir. Enferm Infecc Microbiol Clin. 2002;20:418.
5. Kikuchi Y, Genka I, Ishizaki A, et al. Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome. Clin Infect Dis. 2002;35:488-490.
6. Yotsumoto M, Kitano K, Saito H. Bradycardia-tachycardia syndrome induced by lopinavir-ritonavir in a patient with AIDS. AIDS. 2005;19:1547-1548.
7. Anson BD, Weaver JG, Ackerman MJ, et al. Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005;365:682-686